(BARN) Barry Callebaut - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0009002962
BARN: Chocolates, Cocoa, Fillings, Coatings, Nuts
Barry Callebaut AG is a global leader in the chocolate and cocoa industry, operating as a key supplier to food manufacturers, artisans, and professional chocolatiers. The company specializes in producing high-quality chocolate, cocoa, and related products, offering a wide range of solutions tailored to diverse customer needs. Its portfolio includes chocolates, compounds, cocoa powder, fillings, coatings, and decorations, among other products. Barry Callebaut serves a broad customer base, from large food manufacturers to small artisanal chocolatiers, providing both standardized and customizable solutions.
Headquartered in Zurich, Switzerland, the company operates a global network of manufacturing facilities and sales offices, with a strong presence in Western Europe, North America, and emerging markets. Barry Callebaut has a long-standing commitment to sustainability, focusing on ethical sourcing of cocoa, reducing environmental impact, and improving the livelihoods of cocoa farmers. The company also invests heavily in innovation, leveraging its CHOCOLATE ACADEMY centers to provide training and research services to customers and professionals in the chocolate industry.
Barry Callebaut AG has a market capitalization of 4,154.30M CHF, with a trailing P/E ratio of 21.78 and a forward P/E of 9.24, indicating potential undervaluation in the near term. The stock currently trades at 765.00 CHF, below its SMA 20, SMA 50, and SMA 200 levels of 939.90, 1049.34, and 1257.48, respectively, suggesting bearish momentum. The average trading volume over the past 20 days is 24,401 shares, with an ATR of 44.90, reflecting moderate volatility.
3-Month Forecast - Technical Outlook: The stock is likely to remain under pressure in the near term, with resistance at SMA 50 (1049.34) and SMA 200 (1257.48). Support levels are limited, with potential downside risk if the stock breaks below its current price range. - Fundamental Outlook: The forward P/E of 9.24 suggests improving earnings expectations, driven by cost optimization and growth in emerging markets. The companys focus on sustainability and innovation is expected to support long-term growth.Additional Sources for BARN Stock
BARN Stock Overview
Market Cap in USD | 5,023m |
Sector | Consumer Defensive |
Industry | Confectioners |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception |
BARN Stock Ratings
Growth Rating | -74.7 |
Fundamental | -0.35 |
Dividend Rating | 49.6 |
Rel. Strength | -54 |
Analysts | - |
Fair Price Momentum | 596.99 CHF |
Fair Price DCF | - |
BARN Dividends
Dividend Yield 12m | 2.77% |
Yield on Cost 5y | 1.72% |
Annual Growth 5y | 2.21% |
Payout Consistency | 86.3% |
BARN Growth Ratios
Growth Correlation 3m | -15.2% |
Growth Correlation 12m | -83.9% |
Growth Correlation 5y | -73% |
CAGR 5y | -15.06% |
CAGR/Max DD 5y | -0.23 |
Sharpe Ratio 12m | -0.60 |
Alpha | -47.77 |
Beta | -0.208 |
Volatility | 45.57% |
Current Volume | 26.2k |
Average Volume 20d | 25.7k |
As of May 01, 2025, the stock is trading at CHF 741.00 with a total of 26,183 shares traded.
Over the past week, the price has changed by -3.45%, over one month by -36.77%, over three months by -26.05% and over the past year by -48.83%.
Neither. Based on ValueRay Fundamental Analyses, Barry Callebaut is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -0.35 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BARN as of May 2025 is 596.99. This means that BARN is currently overvalued and has a potential downside of -19.43%.
Barry Callebaut has no consensus analysts rating.
According to ValueRays Forecast Model, BARN Barry Callebaut will be worth about 644.8 in May 2026. The stock is currently trading at 741.00. This means that the stock has a potential downside of -12.99%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 1358.1 | 83.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 644.8 | -13% |